Select Page

Category: Press Releases

Researchers at Cancer Treatment Centers of America in suburban Chicago evaluating investigational medication for HER2-positive breast cancer

Cancer Treatment Centers of America® (CTCA) today announced it is enrolling patients in a clinical study designed to evaluate a potential new treatment option for patients with HER2-positive breast cancer. The hospital is the only center to offer the study north of Niles, Illinois, and is the closest location to Milwaukee, Wisconsin. The randomized pivotal study, called HER2CLIMB, will evaluate the investigational medication tucatinib in combination with standard treatments for patients with locally advanced or metastatic HER2-positive (HER2+) breast cancer, with or without brain metastases.

Read More

IDPH receives massive donation for synthetic cannabinoids treatment

The Illinois Department of Public Health (IDPH) has been working with the Bausch Foundation, the independent charitable organization of Valeant Pharmaceuticals International, Inc. (Valeant) to secure a donation of nearly 800,000 tablets of vitamin K. The tablets will provide treatment for people who have suffered severe bleeding after using synthetic cannabinoids (spice, K2, etc.) laced with rat poison. A chemical found in rat poison, brodifacoum, prevents blood from clotting, resulting in severe bleeding. High doses of vitamin K taken over several months can help restore the blood’s ability to clot.

Read More
Loading

Subscribe

Support our Advertisers

Advertise With Us

 
health-news-illinois-advertisers-01